Literature DB >> 27154809

Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Christian Benzing1, Nicco Krezdorn2, Julia Förster3, Andreas Hinz4, Felix Krenzien5, Georgi Atanasov5, Moritz Schmelzle5, Hans-Michael Hau3, Michael Bartels3.   

Abstract

BACKGROUND: This study seeks to examine the impact of orthotopic liver transplantation (OLT) on Health-Related Quality of Life (HRQoL) and mental health in patients with different MELD scores.
METHODS: Patients who has undergone orthotopic liver transplant (OLT) or were on the waiting list for OLT were submitted to HRQoL and depression/anxiety assessment by questionnaire: Short-Form 36 (SF-36), Questions on Life Satisfaction (FLZ-M), Patient Health Questionnaire-4 (PHQ-4). Data were analysed following division of patients into three groups: pretransplant patients with a MELD score <10, ≥10, and OLT recipients.
RESULTS: The surveys were sent to 940 consecutive patients within one week in June 2013. Of these 940 patients, 869 (92.4%) met the inclusion criteria. In total, 291 (33.5%) eligible questionnaires (OLT group: 235, MELD <10: 25; MELD _10: 31) were suitable for analysis. General health (GH), vitality (VIT), and mental health (MH) were lower in both pretransplant groups compared to the OLT group (all p < 0.05). Anxiety and depression were higher in the MELD <10 group than in the OLT group (anxiety: p < 0.05; depression: p < 0.01). DISCUSSION: Patients with low MELD scores seem to benefit from OLT with regards to HRQoL and mental health.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27154809      PMCID: PMC4857066          DOI: 10.1016/j.hpb.2016.01.546

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  42 in total

1.  Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

Authors:  Ma Somsouk; Rachel Kornfield; Eric Vittinghoff; John M Inadomi; Scott W Biggins
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

Review 2.  Liver transplantation: a systematic review of long-term quality of life.

Authors:  Linda S Yang; Leonard L Shan; Akshat Saxena; David L Morris
Journal:  Liver Int       Date:  2014-04-23       Impact factor: 5.828

3.  MELD fails to measure quality of life in liver transplant candidates.

Authors:  Sammy Saab; Ayman B Ibrahim; Alexander Shpaner; Zobair M Younossi; Cindy Lee; Francisco Durazo; Steven Han; Karl Esrason; Victor Wu; Jonathan Hiatt; Douglas G Farmer; R Mark Ghobrial; Curtis Holt; Hasan Yersiz; Leonard I Goldstein; Myron J Tong; Ronald W Busuttil
Journal:  Liver Transpl       Date:  2005-02       Impact factor: 5.799

4.  Health-related quality of life: two decades after liver transplantation.

Authors:  Kara M Sullivan; David M Radosevich; John R Lake
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

Review 7.  A review of quality of life instruments used in liver transplantation.

Authors:  Colleen L Jay; Zeeshan Butt; Daniela P Ladner; Anton I Skaro; Michael M Abecassis
Journal:  J Hepatol       Date:  2009-07-28       Impact factor: 25.083

8.  Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation.

Authors:  Sarwa Darwish Murad; Julie K Heimbach; Gregory J Gores; Charles B Rosen; Joanne T Benson; W Ray Kim
Journal:  Liver Transpl       Date:  2013-04-09       Impact factor: 5.799

9.  Correlation of health-related quality of life after liver transplant with the Model for End-Stage Liver Disease score.

Authors:  Eric T Castaldo; Irene D Feurer; Robert T Russell; C Wright Pinson
Journal:  Arch Surg       Date:  2009-02

10.  Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?

Authors:  James R Rodrigue; David R Nelson; Alan I Reed; Douglas W Hanto; Michael P Curry
Journal:  Prog Transplant       Date:  2011-09       Impact factor: 1.065

View more
  7 in total

1.  Quality of Life Domains in Breast Cancer Survivors: The Relationship Between Importance and Satisfaction Ratings.

Authors:  Andreas Hinz; Markus Zenger; Bjarne Schmalbach; Elmar Brähler; Dirk Hofmeister; Katja Petrowski
Journal:  Front Psychol       Date:  2022-06-22

Review 2.  [Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver].

Authors:  M Schmelzle; F Krenzien; W Schöning; J Pratschke
Journal:  Chirurg       Date:  2018-11       Impact factor: 0.955

3.  Analysis of Quality of Life, Depression, and Sexual Function in Patients on the Liver Transplant List.

Authors:  Cihan Fidan; Aydıncan Akdur; Mahir Kırnap; Haldun Selçuk; Sedat Yıldırım; Gökhan Moray; Mehmet Haberal
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

4.  Primary liver transplantation and liver retransplantation: comparison of health-related quality of life and mental status - a cross-sectional study.

Authors:  Johannes Broschewitz; Georg Wiltberger; Nicco Krezdorn; Felix Krenzien; Julia Förster; Georgi Atanasov; Hans-Michael Hau; Moritz Schmelzle; Andreas Hinz; Michael Bartels; Christian Benzing
Journal:  Health Qual Life Outcomes       Date:  2017-07-21       Impact factor: 3.186

5.  MELD Score Reflects the Mood, Sleep, and Daily Living Ability in Liver Transplantation Candidates: A Descriptive Study.

Authors:  Kaiji Ni; Chenglin Li; Yongbing Qian; Xia Sun; Yan Zhan; Ting Zeng; Siqi Zhu; Qiang Xia; Wei Feng; Yanli Luo
Journal:  Ann Transplant       Date:  2020-12-01       Impact factor: 1.530

6.  The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice.

Authors:  Alessandra Agnese Grossi; Federico Nicoli; Tullia Maria De Feo; Massimo Cardillo; Gabriella Biffa; Renzo Pegoraro; Carlo Petrini; Rosanna Torelli; Francesca Puoti; Giuseppe Rossini; Giuseppe Piccolo; Sergio Vesconi; Enrico Minetti; Barbara Pozzo; Giuseppe Vanacore; David Paredes; Paolo Antonio Grossi; Mario Picozzi
Journal:  Transplant Direct       Date:  2021-10-22

7.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.